
Avis Budget Group, Inc. (CAR)
$
96.47
-0.27 (-0.28%)
Key metrics
Financial statements
Free cash flow per share
-46.6761
Market cap
3.4 Billion
Price to sales ratio
0.2914
Debt to equity
-11.9195
Current ratio
0.7062
Income quality
1.7485
Average inventory
0
ROE
0.3455
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Avis Budget Group, Inc., along with its subsidiaries, provides a comprehensive range of car and truck rentals, car sharing, and ancillary services to both businesses and consumers. The company operates under the Avis brand, which delivers premium vehicle rental and mobility solutions tailored for the commercial and leisure segments of the travel industry. Furthermore, the Budget Truck brand specializes in local and one-way truck and cargo van rentals, boasting a fleet of approximately 20,000 vehicles available through a network of around 465 dealer-operated and 385 company-operated locations across the continental United States, serving consumer and light commercial needs. Additionally, the Zipcar brand enhances the offering with its car-sharing network. Avis Budget Group also manages several other car rental brands, including Budget, Payless, Apex, Maggiore, MoriniRent, FranceCars, Amicoblue, Turiscar, and ACL Hire. The company provides a variety of optional insurance products and coverages, such as supplemental liability, personal accident, personal effects protection, emergency sickness protection, and automobile towing protection, alongside cargo insurance options. Additional offerings include fuel service alternatives, roadside assistance, electronic toll collection services, curbside delivery, tablet rentals, satellite radio access, portable navigation units, and child safety seat rentals. The company also supplies moving equipment and accessories, such as hand trucks and furniture pads, as well as a Business Intelligence solution through an online portal for corporate travel. Avis Budget Group, Inc. operates in approximately 10,400 locations globally. The financial data pertains to the fiscal year 2025 during which the company recorded an operating income of $4,348,000,000.00 reflecting its earnings from core operations. The earnings per share (EPS) is reported at -$25.25 indicating the company's profitability on a per-share basis. Furthermore, the net total of other income and expenses is $0.00 reflecting non-core financial activities, while the company earned an interest income of $0.00 showcasing its financial investments. In the investment landscape, the stock of Avis Budget Group, Inc. is reasonably priced at $157.66 appealing to a broad range of investors. The stock has an average trading volume of 534,208.00 indicating moderate liquidity. With a mid-range market capitalization of $3,395,453,818.00 the company is recognized as a steady performer within its domain. It is a key player in the Rental & Leasing Services industry, contributing significantly to the overall market landscape. Additionally, it belongs to the Industrials sector, driving innovation and growth.
Investing in Avis Budget Group, Inc. (CAR) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as C, with a Bearish outlook. Always conduct your own research before investing.
Analysts predict Avis Budget Group, Inc. stock to fluctuate between $54.03 (low) and $212.81 (high) in the next 365 days, reflecting market expectations and potential volatility.
As of 2026-02-20, Avis Budget Group, Inc.'s market cap is $3,395,453,818, based on 35,196,992 outstanding shares.
Compared to GE Aerospace, Avis Budget Group, Inc. has a Lower Market-Cap, indicating a difference in performance.
Avis Budget Group, Inc. pays dividends. The current dividend yield is 5.19%, with a payout of $10 per share.
To buy Avis Budget Group, Inc. (CAR) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for CAR. Place an order (Market, Limit, etc.).
The best time to invest depends on market trends and technical indicators, which show a Bearish trend based on economic conditions and company performance.
Avis Budget Group, Inc.'s last stock split was 1:10 on 2006-09-05.
Revenue: $11,652,000,000 | EPS: -$25.25 | Growth: -50.71%.
Visit https://www.avisbudgetgroup.com/investor-relations for detailed financial reports.
You can explore historical data from here
All-time high: $545.11 (2021-11-02) | All-time low: $54.03 (2025-03-13).
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News

seekingalpha.com
Avis Budget Group, Inc.'s Q4 2025 results were a broad miss: $2.66B revenue vs. $2.75B Street, FY25 revenue $11.65B, missing consensus for the third straight year. The big shock was profitability with FY25 adj. EBITDA is coming in at $748M vs. the original >$1B target (later cut to $900M–$1.0B), plus near-zero Q4 EBITDA vs. $157M guided. The international segment turned around in 2025 but still remains a minor revenue contributor (23% of Q4 revenue) vs. the Americas region.

seekingalpha.com
Avis Budget Group, Inc. (CAR) Q4 2025 Earnings Call Transcript

fool.com
Avis Budget Group took a massive write-down on its EVs last quarter, tumbling the shares for a loss. Avis lost even more money in 2024 than in 2025, and might actually earn a profit in 2026.

seekingalpha.com
CAR Group Limited (CSXXY) Q2 2026 Earnings Call Transcript

globenewswire.com
BRISBANE, Calif., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST) (“Tempest”), a clinical-stage biotechnology company with a pipeline of advanced strategic therapeutic assets, today announced the closing of a previously announced transaction pursuant to which Tempest acquired certain dual-targeting chimeric antigen receptor (CAR)-T programs and obtained financing support from Factor Bioscience Inc. and its affiliates (collectively, “Factor”) in an all-stock transaction resulting in a diverse portfolio including clinical-stage product candidates and an extended runway with multiple potential near-term milestones (the “Transaction”).

globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Car-Mart (CRMT) To Contact Him Directly To Discuss Their Options

globenewswire.com
BROAD ARROW TO HOST PREVIEW OF SELECT CARS SET FOR UPCOMING CALENDAR AT ROLAND-GARROS STADIUM FROM 27 TO 30 JANUARY 2026 | HIGHLIGHTS OF THE GLOBAL ICONS: ONLINE PREVIEW INCLUDE MICHAEL SCHUMACHER'S 1992 BENETTON B192 FORMULA ONE CAR, 1971 LAMBORGHINI MIURA P400 S, 1967 FERRARI 275 GTS, AND IMPORTANT MOTORSPORT MEMORABILIA | EX-ROLAND GARROS TYPE 18 BUGATTI, ‘BLACK BESS' WILL BE DISPLAYED AT ROLAND-GARROS STADIUM PREVIEW COURTESY OF THE LOUWMAN MUSEUM | BROAD ARROW STAND AT RÉTROMOBILE TO PREVIEW EARLY HIGHLIGHTS FOR CONCORSO D'ELEGANZA VILLA D'ESTE SALE: BUGATTI TYPE 43 ROADSTER AND FERRARI F40 BROAD ARROW TO HOST PREVIEW OF SELECT CARS SET FOR UPCOMING CALENDAR AT ROLAND-GARROS STADIUM FROM 27 TO 30 JANUARY 2026 | HIGHLIGHTS OF THE GLOBAL ICONS: ONLINE PREVIEW INCLUDE MICHAEL SCHUMACHER'S 1992 BENETTON B192 FORMULA ONE CAR, 1971 LAMBORGHINI MIURA P400 S, 1967 FERRARI 275 GTS, AND IMPORTANT MOTORSPORT MEMORABILIA | EX-ROLAND GARROS TYPE 18 BUGATTI, ‘BLACK BESS' WILL BE DISPLAYED AT ROLAND-GARROS STADIUM PREVIEW COURTESY OF THE LOUWMAN MUSEUM | BROAD ARROW STAND AT RÉTROMOBILE TO PREVIEW EARLY HIGHLIGHTS FOR CONCORSO D'ELEGANZA VILLA D'ESTE SALE: BUGATTI TYPE 43 ROADSTER AND FERRARI F40

globenewswire.com
SOUTH SAN FRANCISCO, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T) products for cancer and autoimmune disease, today outlined 2026 as a program-defining year for allogeneic CAR T, with multiple first-half clinical readouts expected to test, and potentially validate, whether off-the-shelf CAR T can be delivered at biologic-like scale, in real-world settings, across oncology and autoimmune disease.

globenewswire.com
EXTREMELY RARE OPPORTUNITY TO ACQUIRE THE F1 CAR IN WHICH MICHAEL SCHUMACHER WON HIS FIRST GRAND PRIX IN BELGIUM IN 1992 | BENETTON B192-05 USED EXCLUSIVELY BY SCHUMACHER IN FIVE GRANDS PRIX DURING 1992 F1 SEASON | THE LAST RACE-WINNING F1 CAR TO USE A MANUAL GEARBOX | CAR WAS RETAINED BY BENETTON BEFORE BECOMING PART OF THE RENAULT CLASSIC COLLECTION AND HAS NEVER BEFORE BEEN OFFERED FOR PUBLIC SALE | PART OF THE BROAD ARROW GLOBAL ICONS: EUROPE ONLINE SALE OPEN FROM 23-30 JANUARY 2026 EXTREMELY RARE OPPORTUNITY TO ACQUIRE THE F1 CAR IN WHICH MICHAEL SCHUMACHER WON HIS FIRST GRAND PRIX IN BELGIUM IN 1992 | BENETTON B192-05 USED EXCLUSIVELY BY SCHUMACHER IN FIVE GRANDS PRIX DURING 1992 F1 SEASON | THE LAST RACE-WINNING F1 CAR TO USE A MANUAL GEARBOX | CAR WAS RETAINED BY BENETTON BEFORE BECOMING PART OF THE RENAULT CLASSIC COLLECTION AND HAS NEVER BEFORE BEEN OFFERED FOR PUBLIC SALE | PART OF THE BROAD ARROW GLOBAL ICONS: EUROPE ONLINE SALE OPEN FROM 23-30 JANUARY 2026

zacks.com
CAR's rental-led growth shines as Q4 2025 revenues and earnings are set to rise, backed by fleet efficiency, tech upgrades and the premium Avis First launch.
See all news